RecallGuide.ca
    Health productsUpdated Jan 3, 2026Sun Pharma Canada IncOfficial source

    TARO-GLICLAZIDE MR recall in Canada: may contain pink stain

    Share:

    In plain language

    This recall involves TARO-GLICLAZIDE MR tablets sold in Canada. It's being recalled because some tablets may have a pink stain identified as Candesartan Cilexetil. Consult your healthcare provider before stopping use and follow the return steps in the official notice.

    What to do

    • Verify if your product is affected.
    • Consult your healthcare provider prior to discontinuing use.
    • Contact Sun Pharma Canada Inc. if you have questions.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • TARO-GLICLAZIDE MR

      Lot: PTF5132A

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the lot number

      Lot numbers identify specific production batches.

      Affected lots: PTF5132A

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    This recall involves TARO-GLICLAZIDE MR tablets sold in Canada. It's being recalled because some tablets may have a pink stain identified as Candesartan Cilexetil. Consult your healthcare provider before stopping use and follow the return steps in the official notice.

    What should consumers do?

    Verify if your product is affected. Consult your healthcare provider prior to discontinuing use. Contact Sun Pharma Canada Inc. if you have questions.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    A potential safety risk has been identified with this product. Stop using it immediately and follow the instructions in the official recall notice.

    When was this product recalled?

    This product was recalled on May 22, 2025.

    Is the Sun Pharma Canada Inc brand affected by this recall?

    Yes, Sun Pharma Canada Inc products are affected by this recall. This recall involves TARO-GLICLAZIDE MR tablets sold in Canada. It's being recalled because some tablets may have a pink stain identified as Candesartan Cilexetil. Consult your healthcare provider before stopping use and follow the return steps in the official notice.